Robert Leventhal
Gastroenterology · Waterbury, CTNPI 1275506214
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Echosens North America, Inc. accounts for 63.1% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2020 at $6,098 and has fallen 98.6% since, to $87 in 2025.
Across 322 payments — averaging $49.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Echosens North America, Inc.$10K
- AbbVie$2K
- Gilead$577
- Bristol Myers Squibb$557
- Johnson & Johnson$482
- Takeda Pharmaceuticals U.S.A., Inc.$442
- plus $2K from 19 others
Across 14 payments — averaging $3081.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$18K
- AbbVie$14K
- Intercept Pharmaceuticals, Inc.$12K
What the payments were for
- Consulting fees$4,07525%
- Speaking & faculty fees$6,06038%
- Food & beverage$5,91637%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Echosens North America, Inc. | 11 | $10,135 |
| AbbVie(2 entities) | 110 | $1,828 |
| Gilead | 35 | $577 |
| Bristol Myers Squibb | 24 | $557 |
| Johnson & Johnson(2 entities) | 31 | $482 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $442 |
| Pfizer | 19 | $325 |
| Intercept Pharmaceuticals, Inc. | 6 | $310 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $272 |
| Medtronic | 3 | $227 |
| QOL Medical, LLC | 6 | $135 |
| Daiichi Sankyo Inc. | 5 | $106 |
| Ironwood Pharmaceuticals, Inc | 5 | $102 |
| Aerin Medical Inc. | 1 | $87 |
| Merck | 4 | $78 |
| Ardelyx, Inc. | 4 | $77 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Shionogi Inc | 3 | $50 |
| Redhill Biopharma Inc. | 3 | $43 |
| Evoke Pharma, Inc. | 2 | $40 |
| Organon | 2 | $38 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Ambu Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,051 in reported general payments places this provider in the 85th percentile of 326 gastroenterology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 15 | $10,917 |
| Dexlansoprazole DrDexlansoprazole | 21 | $7,740 |
| Dicyclomine Hcl | 80 | $2,441 |
| Pantoprazole Sodium | 60 | $664 |
| Amitriptyline Hcl | 34 | $525 |
| Omeprazole | 25 | $402 |
| Lansoprazole | 11 | $259 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,828 | $10,91715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 326 gastroenterology providers in Connecticut.
Other gastroenterology in Waterbury
- Hector PunWaterbury$22K
- Paul FeuerstadtHamden$1M
- James FrestonFarmington$772K
- Loren LaineWest Haven$451K
- Martin HoffmanHartford$317K
- Colin SwalesHartford$285K
- Joseph CappaGlastonbury$200K
- Renuka UmashankerHamden$197K
- David HassHamden$173K
- Michael EinsteinHartford$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.